HIGHLIGHTS
- who: Cuiying Xie et al. from the United States Clinical Pharmacy Center, Nanfang Hospital, Medical University, Guangzhou, China have published the Article: Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening, in the Journal: (JOURNAL)
- what: As a promising in_vitro model for targeted drug susceptibility testing, the HCC organoids have the advantage of reproducibility and fidelity, reproducing the histological, genetic, and functional characteristics of the original tumor, maintaining good heterogeneity and tumorigenic potential, as well as long-term stable proliferation in_vitro and maintaining relevant tumor characteristics after multiple passages.
SUMMARY . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.